Predict your next investment

Bristol-Myers Squibb - HIV R&D Assets

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Stage

Acquired Unit | Acquired

Valuation

$0000

About Bristol-Myers Squibb - HIV R&D Assets

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.

Bristol-Myers Squibb - HIV R&D Assets Headquarter Location

345 Park Avenue

New York, New York, 10154-0028,

United States

800-332-2056

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.